Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 3,579 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Squamous Cell Carcinoma of Mouth, Intraepithelial Neoplasia
Interventions: 10% FBR containing bioadhesive gel, placebo gel; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Louisville, Kentucky • Chapel Hill, North Carolina • Columbus, Ohio

Conditions: Meningioma, Glioblastoma, Acoustic Neuroma, Brain Cancer, Pituitary Adenoma
Interventions: Panitumumab-IRDye800; Drug
Lead sponsor: Eben Rosenthal; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Herpes Zoster, Neuralgia, Pain, HIV Infections, Peripheral Nervous System Diseases, Diabetic Neuropathies, Diabetes Mellitus, Polyneuropathies
Interventions: Capsaicin Dermal Patch; Drug
Lead sponsor: NeurogesX; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 17
States / cities: Huntsville, Alabama • Mobile, Alabama • Phoenix, Arizona + 14 more

Conditions: Postmenopausal Osteoporosis
Interventions: abaloparatide-sMTS; Combination Product
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 50 Years to 85 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Smoking Cessation
Interventions: Self-help materials, nicotine patch, Smartphone-delivered automated treatment, Counseling; Behavioral · Drug · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Pulmonary Nodule, Lung Cancer
Interventions: Robotic assisted bronchoscopy; Device
Lead sponsor: Auris Health, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 691 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 17
States / cities: Scottsdale, Arizona • Encinitas, California • Rancho Mirage, California + 14 more

Conditions: Smoking Cessation, Tobacco Use Disorder
Interventions: nicotine transdermal system; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 55 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2005
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Basal Cell Carcinoma
Interventions: LC-OCT Imaging; Device
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
Interventions: Not listed
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 40 Years to 90 Years
Enrollment: 435 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 20
States / cities: Birmingham, Alabama • Huntsville, Alabama • Atlanta, Georgia + 14 more

Conditions: Smoking Cessation, Schizophrenia, Schizo Affective Disorder
Interventions: counseling; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 64 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Peripheral Artery Disease
Interventions: Diamondback 360 Extended Length Orbital Atherectomy System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 6
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Lafayette, Louisiana + 2 more

Conditions: Slipping and Falls
Interventions: Slips on Turns, Slips on Slopes; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 35 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Liver Cancer
Interventions: Signa Excite 3.0 T MRI Scan; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Dental Caries
Interventions: Flowable composite, Conventional composite restorative; Device
Lead sponsor: Solventum US LLC; Industry
Eligibility: 19 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Breast Neoplasm
Interventions: Biopsy of Breast, Medical Device Usage and Evaluation, Scintimammography, Technetium Tc-99m Sestamibi; Procedure · Other · Radiation
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Bone Marrow Transplant, Stem Cell Transplant
Interventions: Zoster Vaccine Recombinant; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 79 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Amblyopia
Interventions: patching, binocular games; Other
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 4 Years to 14 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Arrhythmias, Cardiac
Interventions: Cardiac Monitoring; Device
Lead sponsor: ZBeats INC; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Carotid Artery Diseases
Interventions: Transcarotid Artery Revascularization (TCAR); Procedure
Lead sponsor: Silk Road Medical; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 53
States / cities: Huntsville, Alabama • Scottsdale, Arizona • Tucson, Arizona + 49 more

Conditions: Stress, Anxiety
Interventions: PEACE Patch, Topical Sham Patch; Device
Lead sponsor: SuperPatch Limited LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Tyrone, Georgia

Conditions: Advanced or Metastatic Merkel Cell Carcinoma, Advanced or Metastatic Cutaneous Squamous Cell Carcinoma, Advanced or Metastatic Melanoma, Advanced or Metastatic Head and Neck Squamous Cell Carcinoma, Advanced or Metastatic Solid Tumors
Interventions: Cavrotolimod, Pembrolizumab, Cemiplimab; Drug · Biological
Lead sponsor: Exicure, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 26
States / cities: Tucson, Arizona • Orange, California • San Francisco, California + 21 more

Conditions: Actinic Keratosis
Interventions: Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm; Drug
Lead sponsor: Frankel, Amylynne, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Plaque Psoriasis
Interventions: 074-6751 Lotion; Device
Lead sponsor: Ferndale Laboratories, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: Tampa, Florida • Carmel, Indiana • Plainfield, Indiana + 2 more

Conditions: Spina Bifida; Fetus, Myelomeningocele, Myeloschisis
Interventions: NEOX Cord 1K applied fetoscopically; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2036
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)

Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center

Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung

Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1

Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Examining Persistence in Smokers With Schizophrenia

Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI

Mechanisms of Fall Resistance to Diverse Slipping Conditions

Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

Clinical Study on a New Flowable Composite as a Restorative in Adult Teeth

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Shingrix In Recipients of Allogeneic Transplants

Binocular iPad Sub-Study

Artificial Intelligence (AI) Enabled, Cloud-based ECG Diagnostic Solution (ZBPro) Feasibility Testing

Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease

Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment

Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair